Fibrinolytic Activity of Recombinant Mutant Streptokinase
Author(s) -
Mahboobeh Mobarrez,
Mojgan Bandehpour,
Massoud Salehmoghadam,
Bahram Kazemi
Publication year - 2015
Publication title -
novelty in biomedicine
Language(s) - English
DOI - 10.22037/nbm.v3i2.8679
Background: Streptokinase is a bacterial protein produced by different beta hemolytic streptococci and widely used in thrombolytic treatment. The main disadvantage of using streptokinase is antibody formation which causes allergic reaction to neutralize effects of streptokinase therapy. Aim of this study was investigate of recombinant mutant streptokinase fibrinolytic activity. M aterials and Methods: In this study recombinant mutant streptokinase without 42 amino acids from the C terminal region was purified by affinity S-Tag column chromatography and its fibrinolytic activity was studied. R es ults: The concentration of expressed and purified protein was 10 mg/ml. Its enzyme activity was assayed using zymography, radial caseinolytic activity and fibrin plate test methods and estimated quantitatively by casein digestion method compared to a commercial form. C onclusion: It was found that this product had the more volume and more enzymatic activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom